Compare FLS & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FLS | GKOS |
|---|---|---|
| Founded | 1790 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Fluid Controls | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 10.9B |
| IPO Year | 2006 | 2015 |
| Metric | FLS | GKOS |
|---|---|---|
| Price | $79.39 | $184.89 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 12 |
| Target Price | $86.00 | ★ $126.92 |
| AVG Volume (30 Days) | ★ 1.6M | 899.4K |
| Earning Date | 04-29-2026 | 04-29-2026 |
| Dividend Yield | ★ 1.04% | N/A |
| EPS Growth | ★ 23.36 | N/A |
| EPS | ★ 1.41 | N/A |
| Revenue | N/A | ★ $507,442,000.00 |
| Revenue This Year | $6.80 | $23.32 |
| Revenue Next Year | $6.22 | $27.43 |
| P/E Ratio | $55.39 | ★ N/A |
| Revenue Growth | N/A | ★ 32.33 |
| 52 Week Low | $48.71 | $73.16 |
| 52 Week High | $92.41 | $191.62 |
| Indicator | FLS | GKOS |
|---|---|---|
| Relative Strength Index (RSI) | 57.52 | 68.27 |
| Support Level | $76.48 | $96.44 |
| Resistance Level | $82.33 | N/A |
| Average True Range (ATR) | 2.09 | 5.90 |
| MACD | -0.19 | -0.20 |
| Stochastic Oscillator | 47.17 | 76.73 |
Flowserve Corp is a manufacturer and aftermarket service provider of comprehensive flow control systems. It develops precision-engineered flow control equipment to monitor movement and protect customers' materials and processes. It offers an extensive range of pumps, valves, seals, and services for several industries, including oil and gas, chemical, power generation, and water management. It has three business segments: FPD for custom engineered pumps, pre-configured industrial pumps, pump systems, mechanical seals, auxiliary systems and replacement parts and related services; and FCD for engineered-to-order and configured-to-order isolation values, control valves, valve automation products and related equipment and Eliminations and All Other.
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.